Literature DB >> 16696086

Tumour infiltrating lymphocytes: insights into tumour immunology and potential therapeutic implications.

K F Yoong1, D H Adams.   

Abstract

Entities:  

Year:  1996        PMID： 16696086      PMCID： PMC408070          DOI： 10.1136/mp.49.5.m256

Source DB:  PubMed          Journal:  Clin Mol Pathol        ISSN： 1355-2910


× No keyword cloud information.
  132 in total

1.  Tumors arising in organ transplant recipients.

Authors:  I Penn
Journal:  Adv Cancer Res       Date:  1978       Impact factor: 6.242

Review 2.  From defined human tumor antigens to effective immunization?

Authors:  T Boon; T F Gajewski; P G Coulie
Journal:  Immunol Today       Date:  1995-07

3.  Regulatory effects of interleukin-7 on renal tumor infiltrating lymphocytes.

Authors:  P Ditonno; C L Tso; T Sakata; J B deKernion; A Belldegrun
Journal:  Urol Res       Date:  1992

4.  Immunologic effector cells in head and neck cancer.

Authors:  D Vitolo; E M Letessier; J T Johnson; T L Whiteside
Journal:  J Natl Cancer Inst Monogr       Date:  1992

5.  The T-cell receptor V beta gene usage in tumor-infiltrating lymphocytes and blood of patients with hepatocellular carcinoma.

Authors:  E Weidmann; T L Whiteside; R Giorda; R B Herberman; M Trucco
Journal:  Cancer Res       Date:  1992-11-01       Impact factor: 12.701

6.  Little expression of cytokine mRNA by fresh tumour-infiltrating mononuclear leukocytes from glioma and lung adenocarcinoma.

Authors:  M C Gingras; E Roussel; J A Roth; R P Moser
Journal:  Cytokine       Date:  1995-08       Impact factor: 3.861

Review 7.  Manipulation of costimulatory signals to enhance antitumor T-cell responses.

Authors:  J P Allison; A A Hurwitz; D R Leach
Journal:  Curr Opin Immunol       Date:  1995-10       Impact factor: 7.486

8.  The in vivo distribution of autologous human and murine lymphoid cells grown in T cell growth factor (TCGF): implications for the adoptive immunotherapy of tumors.

Authors:  M T Lotze; B R Line; D J Mathisen; S A Rosenberg
Journal:  J Immunol       Date:  1980-10       Impact factor: 5.422

9.  In vitro growth of murine T cells. V. The isolation and growth of lymphoid cells infiltrating syngeneic solid tumors.

Authors:  I Yron; T A Wood; P J Spiess; S A Rosenberg
Journal:  J Immunol       Date:  1980-07       Impact factor: 5.422

10.  Endogenous IL-12 is necessary for rejection of P815 tumor variants in vivo.

Authors:  F Fallarino; C Uyttenhove; T Boon; T F Gajewski
Journal:  J Immunol       Date:  1996-02-01       Impact factor: 5.422
View more
  1 in total

1.  Interleukin 2 restores CD3-zeta chain expression but fails to generate tumour-specific lytic activity in tumour-infiltrating lymphocytes derived from human colorectal hepatic metastases.

Authors:  K F Yoong; D H Adams
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.